NeuroScouting LLC is developing technologies in the field of neuroscience. The firm is able to measure and train the brain systems required for elite performance, as well as those that are compromised in populations impacted with neurological and neurodevelopment disorders. The firm is developing specialized healthcare technologies that target neurological recovery (e.g. in traumatic brain injury) and are conducting efficacy studies evaluating non-pharmacological interventions for patients with Attention Deficit Hyperactivity Disorder (ADHD). While pharmacological interventions remain the most prevalent options for patients suffering from ADHD symptoms across the lifespan, NeuroScouting is evaluating the potential impact of software-based training platforms that target specific neural systems impaired in these patients. These technologies would offer complementary or alternative strategies to improve the brain systems impaired in ADHD in the form of individualized, immersive, and accessible videogames.
